I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Strober, B
410
results:
Search for persons
X
Format
Online (410)
Mediatypes
Articles (Online) (253)
Bookchapter (Online) (7)
OpenAccess-fulltext (150)
Languages
english (325)
french (8)
Sorted by: Relevance
Sorted by: Year
?
1
LB946 Spesolimab controls chronic inflammation in GPP:
Krueger, J.G.
;
Gudjonsson, J.E.
;
Morita, A.
...
Journal of Investigative Dermatology. 144 (2024) 8 - p. S165 , 2024
Link:
https://doi.org/10.1016/..
?
2
Immunogenicity and pharmacokinetics of guselkumab among pat..:
Armstrong, A.
;
Eyerich, K.
;
Conrad, C.
...
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 12 - p. , 2023
Link:
https://doi.org/10.1111/..
?
3
Abrocitinib effect on patient‐reported outcomes in patients..:
Reich, K.
;
Silverberg, J. I.
;
Papp, K. A.
...
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 10 - p. 2047-2055 , 2023
Link:
https://doi.org/10.1111/..
?
4
A much needed metric: Defining reliable and statistically m..:
Strober, L.B.
;
Bruce, J.M.
;
Arnett, P.A.
...
Multiple Sclerosis and Related Disorders. 57 (2022) - p. 103405 , 2022
Link:
https://doi.org/10.1016/..
?
5
The Disease Burden of Generalized Pustular Psoriasis: Real-..:
Lebwohl, M
;
Medeiros, R A.
;
Mackey, R H.
...
Journal of Psoriasis and Psoriatic Arthritis. 7 (2022) 2 - p. 71-78 , 2022
Link:
https://doi.org/10.1177/..
?
6
Super‐response to guselkumab treatment in patients with mod..:
Reich, K.
;
Gordon, K.B.
;
Strober, B.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 12 - p. 2393-2400 , 2022
Link:
https://doi.org/10.1111/..
?
7
Long‐term, durable, absolute Psoriasis Area and Severity In..:
Gooderham, M.
;
Pinter, A.
;
Ferris, L.K.
...
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 6 - p. 855-865 , 2022
Link:
https://doi.org/10.1111/..
?
8
Effect of baseline disease severity on achievement of treat..:
Reich, K.
;
Mrowietz, U.
;
Menter, A.
...
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. 2409-2414 , 2021
Link:
https://doi.org/10.1111/..
?
9
Efficacy and safety of apremilast in patients with moderate..:
Van Voorhees, A.S.
;
Stein Gold, L.
;
Lebwohl, M.
...
British Journal of Dermatology. 185 (2021) 4 - p. 840-842 , 2021
Link:
https://doi.org/10.1111/..
?
10
Bimekizumab Safety in Patients with Moderate to Severe Psor..:
Reich, K
;
Blauvelt, A
;
Lebwohl, M
...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 1 - p. s21 , 2021
Link:
https://doi.org/10.25251..
?
11
Bimekizumab versus Ustekinumab Efficacy Across Subgroups of..:
Strober, B
;
Krueger, JG
;
Magnolo, N
...
SKIN The Journal of Cutaneous Medicine. 5 (2021) 1 - p. s16 , 2021
Link:
https://doi.org/10.25251..
?
12
Tired of not knowing what that fatigue score means? Normati..:
Strober, L.B.
;
Bruce, J.M.
;
Arnett, P.A.
...
Multiple Sclerosis and Related Disorders. 46 (2020) - p. 102576 , 2020
Link:
https://doi.org/10.1016/..
?
13
BMS-986165, un inhibiteur oral sélectif de la tyrosine kina..:
Strober, B.
;
Gottlieb, A.
;
Thaçi, D.
...
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A355-A356 , 2020
Link:
https://doi.org/10.1016/..
?
14
Efficacy of risankizumab in patients with moderate‐to‐sever..:
Strober, B.
;
Menter, A.
;
Leonardi, C.
...
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 12 - p. 2830-2838 , 2020
Link:
https://doi.org/10.1111/..
?
15
Efficacité d'upadacitinib chez des patients atteints de rhu..:
Mease, P.J.
;
Lertratanakul, A.
;
Strober, B.
...
Revue du Rhumatisme. 87 (2020) - p. A31-A32 , 2020
Link:
https://doi.org/10.1016/..
1-15